US Bancorp DE cut its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) by 22.2% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,801 shares of the company’s stock after selling 1,659 shares during the quarter. US Bancorp DE’s holdings in Nu Skin Enterprises were worth $42,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its holdings in shares of Nu Skin Enterprises by 102.0% in the 1st quarter. GAMMA Investing LLC now owns 3,498 shares of the company’s stock valued at $25,000 after purchasing an additional 1,766 shares during the period. New York State Teachers Retirement System acquired a new position in Nu Skin Enterprises in the 1st quarter valued at about $33,000. Public Employees Retirement System of Ohio grew its stake in Nu Skin Enterprises by 28.5% in the 4th quarter. Public Employees Retirement System of Ohio now owns 7,976 shares of the company’s stock valued at $55,000 after buying an additional 1,768 shares during the last quarter. Harbor Capital Advisors Inc. grew its stake in Nu Skin Enterprises by 2,542.6% in the 1st quarter. Harbor Capital Advisors Inc. now owns 9,117 shares of the company’s stock valued at $66,000 after buying an additional 8,772 shares during the last quarter. Finally, Bank of Montreal Can acquired a new position in Nu Skin Enterprises in the 4th quarter valued at about $80,000. 82.84% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other news, Director Edwina D. Woodbury sold 4,532 shares of Nu Skin Enterprises stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $8.44, for a total transaction of $38,250.08. Following the completion of the transaction, the director directly owned 42,947 shares in the company, valued at $362,472.68. This trade represents a 9.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Steven Keith Hatchett purchased 6,500 shares of the business’s stock in a transaction that occurred on Wednesday, May 28th. The shares were purchased at an average price of $7.54 per share, for a total transaction of $49,010.00. Following the completion of the acquisition, the insider owned 162,065 shares of the company’s stock, valued at $1,221,970.10. The trade was a 4.18% increase in their position. The disclosure for this purchase can be found here. 2.00% of the stock is owned by company insiders.
Nu Skin Enterprises Stock Performance
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.25 by $0.18. The business had revenue of $386.14 million during the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises had a net margin of 6.20% and a return on equity of 8.23%. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. As a group, research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 earnings per share for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 10th. Investors of record on Friday, August 29th will be paid a dividend of $0.06 per share. This represents a $0.24 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Friday, August 29th. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 11.94%.
Analysts Set New Price Targets
A number of research analysts recently commented on the stock. Zacks Research upgraded shares of Nu Skin Enterprises to a “hold” rating in a research note on Tuesday, August 12th. Wall Street Zen lowered shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 9th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $6.88.
Read Our Latest Analysis on NUS
About Nu Skin Enterprises
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
Further Reading
- Five stocks we like better than Nu Skin Enterprises
- What is a buyback in stocks? A comprehensive guide for investors
- Buffett’s Cash Hoard Signals Market Caution, Value Plays Emerge
- What Does Downgrade Mean in Investing?
- DLocal Stock Soars 43% After Earnings Beat and Raised Guidance
- 3 Tickers Leading a Meme Stock Revival
- Can AI Defense Contracts Push Palantir Shares Higher?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.